Intervention

FDG PET scan

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions4

Lead sponsors shown3

Clinical trials

3 shown

eMESH Struct. 2022-23NCT05202938 · 2022-07-21

Genotypic Influences on Network Progression in Parkinson's DiseaseNCT04228172 · 2020-02-24

ACTIVE_NOT_RECRUITING

A Pilot Study Evaluating Heart and Lung Metabolism in Pulmonary Hypertension Associated With Left Heart DiseaseNCT02237378 · 2014-12-01

Common conditions

Chronic Heart Failure1 Parkinson's Disease1 Pulmonary Hypertension1 Septic Shock1

Leading sponsors

Centre de recherche du Centre hospitalier universitaire de Sherbrooke1 Northwell Health1 Ottawa Heart Institute Research Corporation1

Trial status mix

ACTIVE_NOT_RECRUITING1

TERMINATED1

UNKNOWN1

Phase mix

NA1

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.